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Background: Odyssean malaria refers to malaria transmitted
by translocated mosquitoes and the term encompasses ‘airport
malaria’, ‘baggage malaria’, ‘taxi malaria,’ and so on. A case of
odyssean malaria is one in which there is no travel history, and
mechanical transmission (byblood transfusion, injectionorneedle-
stick injury) is excluded. Odyssean malaria is therefore a diagnosis
of exclusion, as the probability of ﬁnding the responsible vector
is miniscule. Because of the unexpected nature of the infection,
diagnosis is often delayed and severe and complicated malaria is
common in these patients. Herewe describe outbreaks of odyssean
malaria during the period 2007 through 2013 in Gauteng Province,
South Africa, and alert healthcare workers about this form of
malaria.
Methods&Materials:Most cases came toour attention through
local health authorities in the course of their investigations of
malarianotiﬁcations,whenwewere requested tohelpwith clinical,
epidemiological and entomological aspects. Site visits, environ-
mental hygiene inspections, patient interviews, and entomological
investigations for adultmosquitoesand larvae inpotential breeding
sites were done in each identiﬁed outbreak.
Results: Over the period, 14 laboratory-proven and 7 proba-
ble cases of odyssean malaria were investigated. There were 2
deaths (9.5% case fatality rate, approximately 10 times higher than
the national fatality rate for malaria). Common presentations were
unexplained jaundice, depressed consciousness, and apparent sep-
sis, unresponsive to antibiotics. In the two most recent clusters, a
total of 7 cases with one death occurred on the outskirts of Preto-
ria and Johannesburg in 2013. We believe that road trafﬁc arriving
from endemic areas around South Africa is the source of most of
the infectedmosquitoes.We emphasise the importance of clinician
awareness of this rare but frequently severe form of malaria.
Conclusion: Odyssean malaria cases are inevitable in South
Africa, given the volume of road, rail and air trafﬁc from malaria
riskareas intoGautengandothernon-endemicprovinces. It is likely
that many cases are missed, owing to the rare and sporadic nature
of the condition. Malaria should always be kept in mind as a cause
of unexplained fever and thrombocytopenia, even in the absence
of a travel history.
http://dx.doi.org/10.1016/j.ijid.2014.03.786
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Background: Typhoid fever is a serious systemic infection
caused by the enteric pathogen Salmonella enterica serovar Typhi.
S. Typhi is spread by the faecal–oral route. Enteric fever also affects
short-term and long-term travelers bound to highly endemic areas.
Currently, 2 typhoid vaccines of demonstrated safety and efﬁcacy
are available on the international market, namely the parenteral
Vi polysaccharide vaccine and the live, oral Ty21a vaccine. The Vi
polysaccharide vaccine elicits serum IgG Vi antibody responses in
85–95% of adults and children aged>2 years. The WHO position
on typhoid vaccines is that both the parenteral Vi-based polysac-
charide vaccine and the live oral Ty21a vaccine are internationally
available typhoid vaccines with proven safety, efﬁcacy and pro-
grammatic impact.
Methods & Materials: Retrospective study of the medical
record.
Results: A 30-year old man presented in Rio de Janeiro
with malaise, fever and diarrhea that not improved after symp-
tomatic treatment. He was hospitalized and treatment was started
with ciproﬂoxacin intravenously. Laboratory ﬁndings showed mild
thrombocytopenia and elevated transaminases. There was not leu-
copenia. Blood cultures were negatives but Widal test against
somatic (O) antigens was reagent (1:320). He was discharged after
5 days and treatment was completed with oral ciproﬂoxacin. The
man was born in Australia and he lived in New Zealand where
he was vaccinated for typhoid fever (Vi polysaccharide). Before to
arrive in Brazil he had travelled in Bolivia and Peru for about a
month.
Conclusion: Typhoid fever vaccination may be offered to tra-
vellers to destinations where the risk of typhoid fever is high,
especially to those staying in endemic areas for >1month and/or in
locationswhereantibiotic-resistant strainsof S. Typhiareprevalent.
Although the Vi and the Ty21a vaccines provide appreciable levels
of protection and have a good record of safety, improved vaccines
against typhoid fever are desirable.
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